The clinical outcomes of COVID-19 in HIV-positive patients: A systematic review of current evidence.
SeyedAhmad SeyedAlinaghi,Amirali Karimi,Mehrzad MohsseniPour,Alireza Barzegary,Seyed Peyman Mirghaderi,Amirata Fakhfouri,Solmaz Saeidi,Armin Razi,Hengameh Mojdeganlou,Marcarious M. Tantuoyir,Marcarious M. Tantuoyir,Amir Masoud Afsahi,Esmaeil Mehraeen,Omid Dadras +13 more
Reads0
Chats0
TLDR
In this article, a systematic review was conducted to investigate the impact of COVID-19 on patients infected with HIV, and the authors concluded that HIV patients at advanced stages (3 or 4) of the disease, whose CD4 counts are low, may show less severe infection symptoms.Abstract:
Introduction Patients with chronic underlying diseases are more susceptible to coronavirus disease 2019 (COVID-19) complications. Recent studies showed people living with HIV (PLWH) are not at greater risk than the general population. Few studies have reviewed the impacts of COVID-19 on PLWH. The purpose of this systematic review was to investigate the impact of COVID-19 on patients infected with HIV. Methods We executed a systematic search using four databases of PubMed, Scopus, Science Direct, and Web of Science and screened the records in two steps based on their title/abstract and full text. This study follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist to elevate the validity and reliability of its results. Results We reviewed 36 studies. The patients' age was above 20 years in all studies. In almost all studies, the inflammatory parameters were reported high. In most of the studies, all HIV patients completely recovered from the COVID 19 infection. Although CD4 count was not recorded in all studies, the minimum level was reported as 12 cells/µl. Conclusion Based on the current review, we concluded that HIV patients at advanced stages (3 or 4) of the disease, whose CD4 counts are low, may show less severe COVID-19 infection symptoms. Similarly, Interference can reduce the severity of immune reactions and subsequent cytokine storms and consequently mitigate the symptoms. Therefore, in most of the studies, the majority of HIV patients showed no severe symptoms and completely recovered from COVID 19 infection.read more
Citations
More filters
Journal ArticleDOI
Outcomes of patients with HIV and COVID-19 co-infection: a systematic review and meta-analysis
TL;DR: A systematic review and meta-analysis aimed to summarize the available information on the risk of hospitalization, severe disease, and death attributable to HIV in patients with COVID-19 as discussed by the authors .
Journal ArticleDOI
The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review.
Shahram Oliaei,SeyedAhmad SeyedAlinaghi,Mohammad Mehrtak,Amirali Karimi,Tayebeh Noori,Pegah Mirzapour,Alireza Shojaei,Mehrzad MohsseniPour,Seyed Peyman Mirghaderi,Sanam Alilou,Parnian Shobeiri,Hadiseh Azadi Cheshmekabodi,Esmaeil Mehraeen,Omid Dadras +13 more
TL;DR: A systematic review of studies discussing hyperbaric oxygen therapy (HBOT) to examine its reported efficacy and adverse events in patients with COVID-19 was conducted in this article.
Journal ArticleDOI
Mucormycosis infection in patients with COVID‐19: A systematic review
SeyedAhmad SeyedAlinaghi,Amirali Karimi,Alireza Barzegary,Zahra Pashaei,Amir Masoud Afsahi,Sanam Alilou,Nazanin Janfaza,A Habibzadeh Shojaei,Fatemeh Afroughi,P Mohammadi,Yasna Soleimani,N A Nazarian,Ava Amiri,Marcarious M. Tantuoyir,Sh Oliaei,Esmaeil Mehraeen,Omid Dadras +16 more
TL;DR: Mulormycosis and COVID‐19 co‐infection might adversely affect patients' outcomes, and the related evidence and the subsequent outcomes are reviewed.
Journal ArticleDOI
COVID‐19 in HIV‐positive patients: A systematic review of case reports and case series
Mohsen Heidary,Arezoo Asadi,Negar Noorbakhsh,Shirin Dashtbin,Parisa Asadollahi,Atieh Dranbandi,Tahereh Navidifar,Roya Ghanavati +7 more
TL;DR: The characteristics of COVID‐19 in HIV‐positive patients and the control of human immunodeficiency virus (HIV) has received less attention lately.
Journal ArticleDOI
Incidence of Symptomatic COVID-19 in Unvaccinated Patients Within One Month After Elective Total Joint Arthroplasty: A Multicenter Study
Erfan Sheikhbahaei,S. P. Mirghaderi,Alireza Moharrami,Danial Habibi,Mehdi Motififard,SM Javad Mortazavi +5 more
TL;DR: In this article , the authors investigated the incidence of symptomatic coronavirus disease 2019 (COVID-19) and its related risk factors in unvaccinated patients after TJA within 1 month after discharge in 2 large cities of our country.
References
More filters
WHO Declares COVID-19 a Pandemic.
TL;DR: The Director-General of the World Health Organization, Dr. Tedros Adhanom Ghebreyesus, noted that over the past 2 weeks, the number of cases outside China increased 13-fold and theNumber of countries with cases increased threefold, and further increases are expected.
Journal ArticleDOI
COVID-19: Transmission, prevention, and potential therapeutic opportunities.
TL;DR: Current therapeutic options, preventive methods and transmission routes of COVID-19 are discussed and infection prevention, early viral detection and identification of successful treatment protocols provide the best approach in controlling disease spread.
Journal ArticleDOI
Mathematical Modeling of COVID-19 Transmission Dynamics with a Case Study of Wuhan.
TL;DR: Numerical simulations show the suitability of the proposed COVID-19 model for the outbreak that occurred in Wuhan, China.
Journal ArticleDOI
Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa.
TL;DR: While the findings may over-estimate HIV- and tuberculosis-associated COVID-19 mortality risks due to residual confounding, both HIV and current tuberculosis were independently associated with increased COVID,19 mortality.
Journal ArticleDOI
COVID-19 in patients with HIV: clinical case series.
José Luis Santiago Blanco,Juan Ambrosioni,Felipe García,Esteban Martínez,Alex Soriano,Josep Mallolas,José M. Miró +6 more
TL;DR: The first single-centre experience of COVID-19 in patients infected with HIV-1 is described, to the authors' knowledge, including clinical characteristics, antiviral and antiretroviral treatment, and outcomes.
Related Papers (5)
Outcomes of COVID-19 related hospitalisation among people with HIV in the ISARIC WHO Clinical Characterisation Protocol UK Protocol: prospective observational study
Anna Maria Geretti,Alexander J. Stockdale,Sophie H. Kelly,Muge Cevik,Simon Collins,Laura Waters,Giovanni Villa,Annemarie B Docherty,Ewen M Harrison,Lance Turtle,Peter J. M. Openshaw,J Kenneth Baillie,Caroline A. Sabin,Malcolm G Semple,Malcolm G Semple,Daniel Bradshaw,Alison E Brown,N. Connor,Valerie Delpech,Saye Khoo,Tamyo Mbisa,Chloe Orkin,Ann Sullivan,Isaric C Investigators +23 more